Digital PrEP help for people who use drugs
Part of Infections clinical trials.
This study tests if text messages on Telegram or WhatsApp can help people who use drugs learn about and start taking PrEP, a medicine that prevents HIV. It's for people who don't have HIV and aren't already taking PrEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have used drugs (like heroin, meth, or cocaine) in the past six months.
- You do not have HIV, or you don't know your HIV status.
- You are not currently taking PrEP (HIV prevention pills or shots).
- You have a personal smartphone that can receive messages on Telegram or WhatsApp.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a decision support tool that helps emergency department patients learn about PrEP (a daily pill that prevents HIV). It is for people who are HIV negative and not already taking HIV prevention medicine.
This study tests a smartphone program to help HIV-negative men who have sex with men reduce meth use and improve PrEP adherence. It explores whether combining support for both behaviors is more effective than addressing them separately.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
This trial tests a digital toolkit to help women start taking PrEP, a medication that prevents HIV. It looks at whether the toolkit makes it easier for women to take PrEP consistently.
This trial tests whether phone-based (iPhone/Android) text-message support can improve how consistently people use PrEP, an HIV prevention medicine. It may help you stay on track with refills and clinic visits, especially if you’re at higher risk of stopping PrEP.
Hear when a new Drug Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.